Propionic Acid

Propionic Acid

SCHEMBL906440

CCC(=O)O.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Propionic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120158860-A Durable water-splashing-preventing environment-friendly knitted three-dimensional fabric and production process thereof 东丽酒伊织染(南通)有限公司 2025-06-17 CN claimed
CN-116861341-A Method for predicting sulfur cycle coupling denitrification dephosphorization process performance in two stages 华中科技大学 2023-10-10 CN claimed
CN-110256534-B Purification method of multi-arm anticancer conjugate 高瑞耀业(北京)科技有限公司 2023-08-25 CN claimed
CN-115386273-A Daytime radiation refrigeration coating 南京工业大学 2022-11-25 CN claimed
CN-114853597-A Extractive distillation process and dynamic control scheme of propionic acid-water binary azeotrope 青岛科技大学 2022-08-05 CN claimed
CN-114345406-A Method for preparing epoxy chloropropane by catalyzing epoxidation of 3-chloropropene, catalyst and preparation method 江苏扬农化工集团有限公司 2022-04-15 CN claimed
EP-3642215-A1 CRYSTALLINE FORMS OF BETA-SITOSTEROL Center for Intelligent Research in Crystal Engineering, S.L. (ES) 2020-04-29 EP claimed
CN-107109300-B Unit dose fabric softener 高露洁-棕榄公司 2020-04-17 CN claimed
CN-111032673-A β -sitosterol crystalline form 晶体工程智能研究中心 2020-04-17 CN claimed
US-10428296-B2 Unit dose fabric softener COLGATE-PALMOLIVE COMPANY (US) 2019-10-01 US claimed
EP-0818987-A4 COMPOSITION AND PROCESS FOR PREVENTION AND TREATMENT OF CUTANEOUS IMMEDIATE HYPERSENSITIVITY REACTIONS ASCENT PHARMA INC (US) 2000-05-03 EP claimed
CN-1199754-A Mixed surfactant and hydrophohically-modified polymer compositions ROHM & HAAS (US) 1998-11-25 CN claimed
EP-0818987-A1 COMPOSITION AND PROCESS FOR PREVENTION AND TREATMENT OF CUTANEOUS IMMEDIATE HYPERSENSITIVITY REACTIONS ASCENT PHARMACEUTICALS, INC. (US) 1998-01-21 EP claimed
EP-0818998-A1 COMPOSITION AND PROCESS FOR PREVENTION AND TREATMENT OF CUTANEOUS DELAYED HYPERSENSITIVITY REACTIONS ASCENT PHARMACEUTICALS, INC. (US) 1998-01-21 EP claimed
US-5684038-A WATER IN OIL EMULSION OF 1,3-BIS/2-CARBOXYCHROMON-5-YLOXY/-2-HYDROXYPROPANE ASCENT PHARMACEUTICALS, INC. (US) 1997-11-04 US claimed
WO-1996031203-A1 COMPOSITION AND PROCESS FOR PREVENTION AND TREATMENT OF CUTANEOUS DELAYED HYPERSENSITIVITY REACTIONS ASCENT PHARMACEUTICALS, INC. (US) 1996-10-10 WO claimed
WO-1996031193-A1 COMPOSITION AND PROCESS FOR PREVENTION AND TREATMENT OF CUTANEOUS IMMEDIATE HYPERSENSITIVITY REACTIONS ASCENT PHARMACEUTICALS, INC. (US) 1996-10-10 WO claimed
WO-1996031205-A1 COMPOSITIONS AND PROCESS FOR TREATING UREMIC PRURITUS ASCENT PHARMACEUTICALS, INC. (US) 1996-10-10 WO claimed
WO-1996031204-A1 COMPOSITIONS AND PROCESS FOR TREATING HEMANGIOMA ASCENT PHARMACEUTICALS, INC. (US) 1996-10-10 WO claimed
EP-0146363-B1 SYNERGISTIC PHARMACEUTICAL COMPOSITIONS, THEIR PRODUCTION AND USE CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) 1988-11-17 EP claimed